NEW YORK (GenomeWeb) – The University of Maryland School of Medicine announced it has been awarded a four-year, $3.7 million grant from the National Institutes of Health to develop a personalized medicine program for the diagnosis and treatment of monogenic diabetes.

The National Human Genome Research Institute and the Implementing Genomics in Practice network is providing the funding for the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.